Seven Bridges Announces $45 million in Series A fundraising,

Seven Bridges announced a $45 million in Series A fundraising, led by Kryssen Capital, an international investment fund that focuses on data-driven ventures at the cutting edge of science. The investment will support ongoing innovation of the Seven Bridges Platform, a scalable, cloud-based suite of tools for biomedical data analysis that powers genomic research focused on cancer treatment and precision medicine..
According to James Sietstra, President of Seven Bridges:

Genomic data projects are driving unprecedented progress in the area of precision medicine, including initiatives like the cancer moonshot, which President Obama highlighted in his final State of the Union address. Seven Bridges was founded to accelerate breakthroughs in genomics research, and this round of funding will help us continue to support users at the U.S. National Cancer Institute, the National Institutes of Health, Genomics England and our pharmaceutical partners who are part of the worldwide effort to understand and treat cancer.

Click here to view the full press release.